You are here » Home » Companies » Company Overview » Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd.

BSE: 540025 Sector: Industrials
NSE: ADVENZYMES ISIN Code: INE837H01020
BSE 15:40 | 19 Jan 289.80 -3.80
(-1.29%)
OPEN

296.00

HIGH

296.00

LOW

285.65

NSE 15:44 | 19 Jan 289.70 -4.60
(-1.56%)
OPEN

295.90

HIGH

295.95

LOW

285.70

OPEN 296.00
PREVIOUS CLOSE 293.60
VOLUME 50591
52-Week high 445.00
52-Week low 244.00
P/E 104.62
Mkt Cap.(Rs cr) 3,236
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 296.00
CLOSE 293.60
VOLUME 50591
52-Week high 445.00
52-Week low 244.00
P/E 104.62
Mkt Cap.(Rs cr) 3,236
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Advanced Enzyme Technologies Ltd. (ADVENZYMES) - Chairman Speech

Company chairman speech

Dear Shareholders

On behalf of the Board of Directors and the Management I am very pleased to provideyou the first financial report of your Company post the Initial Public Offering (IPO) andlisting on the Indian Stock Exchanges on 1st August 2016. I would like to inform you thatyour company's IPO received an overwhelming response and was oversubscribed by 82.06times creating a record. This happens to be the 5th best IPO of all times by any Indiancompany to date as reported by Bloomberg. Heartiest Congratulations to all of you onachieving this great milestone !

At the onset I would like to thank each and every shareholder for having shown utmosttrust and confidence on the Company's business model management and business strategy.Today your Company has a Global presence with exports to more than 45 countries. YourCompany is at the forefront of enzyme technology and leverages Research and Development(R&D) to deliver high quality products worldwide. Through sustained efforts andinvestments in R&D over the past two decades your Company has developed a strongportfolio of over 65 enzymes & probiotics.

In spite of the significant challenges faced your Company's revenues and profitabilitytrack record has been remarkably strong in the last 5 years. I owe my gratitude to all ouremployees & associates for their continued dedication commitment and loyalty thathas helped the Company overcome these difficult times.

In the year gone by your Company has forayed decisively into Probiotics. Probiotics isa $1.7 billion market globally and the main applications are in Nutrition &Healthcare. In the past year your Company has also acquired a 70% stake in Hyderabadbased JC Biotech Private Limited. Through this acquisition your Company has strengthenedits presence in a key API Serratiopeptidase and has also acquired competencies &capabilities that are complementary to its existing plants.

I am thankful to each and every one of you for having participated in our journey sofar and look forward to your continued support.

V.L. Rathi
Thanking you. Chairman